SCHEMBL17367474

SCHEMBL17367474

CC(=O)c1ccsc1-c1ccc(-c2ccc(C3(C(C)=O)CC3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.38
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP2C9 P11712 3/20 0.33
CYP2D6 P10635 2/20 0.33
HSD11B1 P28845 2/20 0.33
CYP3A4 P08684 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
APP P05067 2/20 0.33
CYP2C19 P33261 2/20 0.33
AKR1B10 O60218 1/20 0.32
AKR1C4 P17516 1/20 0.32
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
AKR1C1 Q04828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367475 0.89 PTK2 (0.40) PTGS1LMNAL3MBTL1CYP2C9CYP2D6
SCHEMBL17367478 0.82 ALDH1A1 (0.42) PTGS1LMNACYP2C9CYP2D6CYP3A4
SCHEMBL17367479 0.78 MAPT (0.36) L3MBTL1CYP2C9CYP2D6HSD11B1CYP3A4
SCHEMBL17367481 0.78 PTGS1 (0.30) PTGS1CYP2C9CYP2D6CYP3A4HPGD
SCHEMBL17367484 0.78 APP (0.35) CYP2C9CYP2D6CYP3A4APPCYP2C19
SCHEMBL30238017 0.73 PTK2 (0.42) PTGS1LMNAL3MBTL1ALDH1A1MAPT
SCHEMBL1147544 0.72 MAPT (0.50) PTGS1LMNAALDH1A1MAPTHPGD
SCHEMBL17367489 0.71 PRKAB2 (0.40) CYP2C9CYP2D6HSD11B1CYP3A4APP
SCHEMBL17367490 0.71 APP (0.37) CYP2C9CYP2D6CYP3A4APPCYP2C19
SCHEMBL17367487 0.71 PRKAB2 (0.35) CYP2C9CYP2D6APPCYP2C19AKR1B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376160-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND UBE INDUSTRIES, LTD. (JP) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376160-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND LPAR3, LPAR1, LPAR2 PTGS1 2492/4885LMNA 2850/4885L3MBTL1 2826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.